Literature DB >> 25406463

Peak systolic to end diastolic flow velocity ratio is associated with ductal patency in infants below 32 weeks of gestation.

A Smith1, M Maguire2, V Livingstone3, E M Dempsey3.   

Abstract

BACKGROUND: Early diagnosis and effective treatment of the patent ductus arteriosus (PDA) in infants less than 32 weeks gestation remains contentious.
OBJECTIVE: To determine which clinical and echocardiographic parameters are associated with PDA patency in preterm infants less than 32 weeks gestation. DESIGN/
METHODS: This was a prospective cohort study. An echocardiography (echo) was performed within 12-48 h of birth and a follow-up echo at 1 month of life. Parental consent was obtained.
RESULTS: 55 babies were enrolled. Median (range) gestation was 28 (24-31) weeks and birth weight 1090 g (470-1800 g). ECHO 1 demonstrated that 50 babies had a PDA present within 48 h of birth, of which 19 were large (≥2 mm) (36%) and 31 were small (59%) on colour Doppler assessment of duct diameter. Three babies died before 1 month. At 1 month 30 babies still had a PDA (58%), 10 of which were large (19%) and 19 were small (36%). Parameters significantly associated with large PDAs versus no PDA at 1 month were gestational age (26 weeks vs 30 weeks, p=0.002), birth weight (860 g vs 1290 g, p=0.007) and ventilator support at 48 h (80% vs 17%, p=0.001). Echo parameters revealed that ductal size on colour Doppler (2.5 mm vs 1.5 mm, p=0.003), end diastolic flow velocity (57 m/s vs 147 m/s, p<0.001) and peak systolic to end diastolic flow velocity ratio (2.29 vs 1.23, p=0.001) at 48 h were associated with large PDAs at 1 month.
CONCLUSIONS: For infants less than 32 weeks gestation a peak systolic to end diastolic flow velocity ratio>2 within 48 h of birth is associated with a persistent large PDA at 1 month of age. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Keywords:  Cardiology; Neonatology

Mesh:

Year:  2014        PMID: 25406463     DOI: 10.1136/archdischild-2014-306439

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


  7 in total

1.  Acetaminophen to avoid surgical ligation in extremely low gestational age neonates with persistent hemodynamically significant patent ductus arteriosus.

Authors:  D E Weisz; F F Martins; L E Nield; A El-Khuffash; A Jain; P J McNamara
Journal:  J Perinatol       Date:  2016-04-07       Impact factor: 2.521

2.  Value of bedside echocardiography in predicting persistent patency of the ductus arteriosus during the early postnatal period in very low birth weight infants.

Authors:  Tai-Xiang Liu; Xiao-Lu Ma; Jun-Jin Chen; Hui-Jia Lin; Chen-Hong Wang; Ming-Yan Chen; Jia-Jing Ge; Li-Ping Shi
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2022-01-15

3.  Is late treatment with acetaminophen safe and effective in avoiding surgical ligation among extremely preterm neonates with persistent patent ductus arteriosus?

Authors:  Sally Mashally; Rudaina Banihani; Bonny Jasani; Lynne E Nield; Fernando F Martins; Amish Jain; Dany E Weisz
Journal:  J Perinatol       Date:  2021-08-27       Impact factor: 2.521

4.  Development of a Diagnostic Clinical Score for Hemodynamically Significant Patent Ductus Arteriosus.

Authors:  Annemarie Kindler; Barbara Seipolt; Antje Heilmann; Ursula Range; Mario Rüdiger; Sigrun Ruth Hofmann
Journal:  Front Pediatr       Date:  2017-12-22       Impact factor: 3.418

Review 5.  Echocardiographic Evaluation of Patent Ductus Arteriosus in Preterm Infants.

Authors:  Romaine Arlettaz
Journal:  Front Pediatr       Date:  2017-06-21       Impact factor: 3.418

6.  Echocardiographic Diagnosis and Hemodynamic Evaluation of Patent Ductus Arteriosus in Extremely Low Gestational Age Newborn (ELGAN) Infants.

Authors:  Yogen Singh; Alain Fraisse; Omer Erdeve; Begum Atasay
Journal:  Front Pediatr       Date:  2020-11-19       Impact factor: 3.418

Review 7.  Application of NPE in the assessment of a patent ductus arteriosus.

Authors:  David van Laere; Bart van Overmeire; Samir Gupta; Afif El-Khuffash; Marilena Savoia; Patrick J McNamara; Christoph E Schwarz; Willem P de Boode
Journal:  Pediatr Res       Date:  2018-07       Impact factor: 3.756

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.